Vaginal Misodel® in Comparison With Orally Administrated Misoprostol (Cytotec®) at Induction of Labour

• Status: Unknown status
• Trial end date: 2017-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The study will compare orally administrated solution of Misoprostol (Cytotec®) with vaginal slow release (7ug/h) Misoprostol (Misodel®) regarding efficacy and safety during labour.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Karolinska Institutet
• Collaborator: Karlstad Central Hospital
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

Primipara BS ≤ 4p Gestational week >37

Exclusion Criteria:

Multipara Multiples Gestational week <37 BS >4 IUFD Previous uterine surgery